Vaccines

About 60 percent of Israel’s 9.4 million people are fully vaccinated with either a recent second dose or booster dose

Mean levels of anti-Müllerian hormone unchanged from baseline to three months after vaccination among reproductive-aged women

Estimated vaccine effectiveness of full Pfizer-BioNTech vaccination 92 percent for preventing SARS-CoV-2 infection

Study conducted in the U.S. and Mexico shows vaccine 90 percent effective overall, 100 percent effective against moderate-to-severe disease

Agency also reduced the period people must wait between their second dose and booster shot from six to five months

At ≥7 days after second dose, effectiveness of mRNA COVID-19 vaccine was 69 percent against infection, 86 percent against related death

Country-specific information, such as prior vaccination uptake, vaccine hesitancy may influence the effect of COVID-19 certification mandates

Molnupiravir cut the risk for hospitalization and death in high-risk patients by 30 percent

Included in the battle plan announced Tuesday are measures to distribute 500 million free rapid COVID-19 tests to the public